BNA
IBB icon

BankChampaign National Association’s iShares Biotechnology ETF IBB Stock Holding History

BankChampaign National Association’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-65
Closed -$8.11K – 211
2026
Q1 		$8.11K Buy
+65
New +$11.1K 0.01% 176

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

BankChampaign National Association's IBB Position: Q2 2026 in Review

BankChampaign National Association sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 65 shares — an estimated $8.11K sold.

BankChampaign National Association first reported a position in IBB in Q1 2026 and held it in 1 quarter. The position peaked at $8.11K in Q1 2026. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • BankChampaign National Association reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • BankChampaign National Association sold 65 iShares Biotechnology ETF shares in Q2 2026, an estimated $8.11K.
  • BankChampaign National Association first reported a position in iShares Biotechnology ETF in Q1 2026 and held it in 1 quarter.
  • BankChampaign National Association's iShares Biotechnology ETF position peaked at $8.11K in Q1 2026.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on BankChampaign National Association's 13F filing for Q2 2026, filed 23 Jul 2026.